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Abstract
Background: Biological chemistry is very stereospecific. Nonetheless, the diastereotopic oxygen
atoms of diphosphate-containing molecules in the Protein Data Bank (PDB) are often given names
that do not uniquely distinguish them from each other due to the lack of standardization. This issue
has largely not been addressed by the protein structure community.
Results: Of 472 diastereotopic atom pairs studied from the PDB, 118 were found to have names
that are not uniquely assigned. Among the molecules identified with these inconsistencies were
many cofactors of enzymatic processes such as mononucleotides (e.g. ADP, ATP, GTP),
dinucleotide cofactors (e.g. FAD, NAD), and coenzyme A. There were no overall trends in naming
conventions, though ligand-specific trends were prominent.
Conclusion: The lack of standardized naming conventions for diastereotopic atoms of small
molecules has left the ad hoc names assigned to many of these atoms non-unique, which may create
problems in data-mining of the PDB. We suggest a naming convention to resolve this issue. The in-
house software used in this study is available upon request.
A version of the software used for the analyses described in this paper is available at our web site: 
http://digbio.missouri.edu/ddan/DDAN.htm.
Background
Often accompanying the macromolecules deposited in
the Protein Data Bank (PDB) [1] are smaller molecules of
biological importance. Some of these are energy-carrying
cofactors, such as ATP, coenzyme A, and nicotinamide-
adenine dinucleotide (NAD). Some analogs of these mol-
ecules are either drugs or can be used in drug design [2,3].
Like other biologically relevant molecules, many of these
small molecules contain chiral or prochiral centers. An
atom is a chiral center if four different chemical groups are
attached to it. A chiral configuration can be designated R
or S, depending on the arrangement of the attached
groups (Figure 1). If, however, two of these groups are
identical, then the center atom is prochiral, meaning that
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it would become chiral if either of the identical groups
were substituted for a unique group. These two groups are
called diastereotopic, i.e., if either were replaced with a
unique group, the molecule would become one or
another diastereomer. Within a pair of diastereotopic
atoms, one is designated pro-R and the other pro-S, indicat-
ing the configuration of the chiral atom would result from
replacing the diastereotopic atom with a group that has
higher priority than the other groups. Many ligands con-
tain diphosphate groups that contain at least one prochi-
ral phosphorus atom (Figure 2).
The pro-S and pro-R oxygen atoms of nucleic acid strands
are named "OP1" and "OP2", respectively [4]. Many
enzymes treat the pro-R and pro-S oxygen atoms of DNA
and RNA differently [5]. These diastereotopic oxygen
atoms are also treated differently in RNA-intron splicing
[6,7]. Small diphosphate-containing molecules also par-
ticipate in enzymatic reactions in which the distinction
between diastereotopic atoms or groups is important
[5,8,9]. Unfortunately, many of these diastereotopic
atoms do not have standardized names, an issue that has
not been investigated to our knowledge. Consistent nam-
ing of diastereotopic atoms is needful when performing
all-atom superpositioning or all-atom root mean square
deviation (RMSD) calculation [10]. It is also needful for
data mining in the PDB, e.g., structure-based virtual
screening for drug candidates [11,12]. In this paper, we
will conduct a systematic PDB-wide analysis on the dias-
tereotopic atom names of small molecules containing
diphosphate.
Results
Inconsistencies in PDB files
There were 4167 PDB files containing a total of 295 dis-
tinct ligands having prochiral centers that met our strict
criteria. Over half of these ligands (175) had two prochiral
phosphate centers that were adjacent to carbon, and one
had three (OXT from [PDB:2JI7] [13]), for a total of 472
distinct prochiral centers adjacent to carbon. For example,
NAD contains two because it has a diphosphate sand-
wiched between two ribose moieties. Each distinct prochi-
ral center contains a pair of disastereotopic atoms. We
analyzed the names of the atoms at each prochiral center.
Of these distinct centers, 354 had a single naming conven-
tion but 241 of these also only occurred in a single PDB
S and R configurations for chiral centers Figure 1
S and R configurations for chiral centers. (a) S configu-
ration and (b) R configuration, for atoms A, B, C, and D 
when they have the highest, second, third, and lowest priori-
ties, respectively. Notice that when the three highest priority 
groups (A, B, and C) are facing the viewer, they have a coun-
ter-clockwise arrangement in the S configuration and a clock-
wise arrangement in the R configuration.
NAD molecules from X-ray crystal structure 2OHX Figure 2
NAD molecules from X-ray crystal structure 2OHX. 
For comparison purposes, one molecule is superimposed on 
the other and then offset slightly. The atom names are simi-
larly offset for the diastereotopic oxygen atoms of the ade-
nine-side phosphate group. Note the differences in names for 
the pro-R and pro-S atoms. Both molecules of NAD shown 
are from an alcohol dehydrogenase structure 
[PDB:2OHX][16]. Following the CIP-algorithm, since all four 
oxygen atoms have the same atomic number, their priority is 
determined by subsequent bonded groups. The O3 oxygen 
atom is bonded to the next phosphorus atom and the O5' 
oxygen atom is bonded to the preceding C5' carbon atom, 
while the remaining two oxygen atoms are unbonded except 
to the original phosphorus atom. Therefore, the O3 oxygen 
atom has the highest priority, the O5' oxygen atom has the 
second highest priority, and the remaining two oxygen atoms 
tie for the lowest priority. The pro-S atom is the one that, if it 
were replaced with an atom of highest priority, would make 
the phosphorus atom chiral with an S configuration. Both 
molecules are drawn using red for oxygen, blue for nitrogen, 
and orange for phosphorus. One is drawn using light blue for 
carbon and the other is drawn using white for carbon.BMC Bioinformatics 2008, 9(Suppl 9):S16 http://www.biomedcentral.com/1471-2105/9/S9/S16
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file. There were 118 distinct prochirality centers that had
more than one naming convention.
We defined a case of swapped names to occur when all of
the following were true between two molecules with the
same type of prochiral center: (1) the highest and second
highest priority names were consistent, (2) the pro-R atom
of one prochiral center had the same name as the pro-S
atom of a second center, and (3) the pro-S atom of the first
center had the same name as the pro-R atom of the second
center (Figure 2). 117 of the 118 centers had swapped
naming conventions as defined above. The remaining
center, which had two naming conventions, actually had
a naming error. Nine of the 117 centers with swapped
names had additional naming conventions. In every case,
we found that the extra naming conventions were caused
by errors rather than mere inconsistencies. For example,
in a structure of a surfactin synthetase-activating enzyme
[PDB:1QR0] [14], the diastereotopic atoms attached to
phosphorus atom P1A are labeled "O5A" and "O4A"
instead of the names "O2A" and "O1A" defined in the
Chemical Component Dictionary http://deposit.rcsb.org/
het_dictionary.txt from the PDB. In a similar manner, the
diastereotopic atoms attached to P2A are named "O2A"
and "O1A", instead of the names "O5A" and "O4A"
defined in the dictionary file. In another example, in a
structure of E. coli carbamoyl phosphate synthetase
[PDB:1CE8] [15] the O5' oxygen atom is mislabeled as
O4' for 8 different ADP molecules. Interestingly, in four of
these molecules, the pro-S and pro-R atoms are labeled
"O1A" and "O2A", respectively, while in the other four
molecules they are labeled "O2A" and "O1A", respec-
tively.
In Table 1, we present statistics for sample cases in which
there were at least two nonredundant examples of each
naming convention. For additional selected examples, see
Supplement Table 1 in Additional File 1. For our full
results, including cases that had no inconsistencies, see
Supplemental Table 2 in Additional File 2 (explanation in
Additional file 3). All results, including those resulting
from errors, are included in Supplemental Table 2. How-
Table 1: Naming convention statistics for selected ligands
ligand code ligand name center atom pro-S pro-R # bias (%) example PDB
ACO acetyl-coenzyme A P1A O1A O2A 22 42% 1DM3
O2A O1A 30 58% 1B87
P2A O4A O5A 25 48% 1B87
O5A O4A 27 52% 1DM3
ADP adenosine-5'-diphosphate PA O1A O2A 211 33% 1A6E
O2A O1A 419 67% 13PK
ATP adenosine-5'-triphosphate PA O1A O2A 103 30% 1B0U
O2A O1A 240 70% 1A0I
COA coenzyme A P1A O1A O2A 67 45% 1ACA
O2A O1A 81 55% 1CM0
P2A O4A O5A 67 46% 1ESM
O5A O4A 78 54% 1ACA
CTP cytidine-5'-triphosphate PA O1A O2A 20 49% 1GQ9
O2A O1A 21 51% 1COZ
FAD flavin-adenine dinucleotide P O1P O2P 554 87% 1A8P
O2P O1P 81 13% 1B2R
PA O1A O2A 290 46% 1AHV
O2A O1A 345 54% 1A8P
GTP guanosine-5'-triphosphate PA O1A O2A 35 36% 1CKM
O2A O1A 62 64% 1A8R
NAD nicotinamide-adenine-dinucleotide PA O1A O2A 144 27% 1A5Z
O2A O1A 388 73% 1A4Z
PN O1N O2N 394 74% 1A4Z
O2N O1N 135 26% 1A7A
NAP nadp nicotinamide-adenine-dinucleotide phosphate PA O1A O2A 87 26% 1CIV
O2A O1A 247 74% 1A27
PN O1N O2N 280 83% 1A27
O2N O1N 58 17% 1A80
TPP thiamine diphosphate (i.e. vitamin B1) PA O1A O2A 25 56% 1AY0
O2A O1A 20 44% 1B0P
UDP uridine-5'-diphosphate PA O1A O2A 80 79% 1BGU
O2A O1A 21 21% 1C3J
# = number of PDB files in which the given naming convention was observed.BMC Bioinformatics 2008, 9(Suppl 9):S16 http://www.biomedcentral.com/1471-2105/9/S9/S16
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ever, we emphasize that the bulk of the results are due to
inconsistencies, not errors.
Examples of naming inconsistencies
Most of the atom naming inconsistencies mentioned in
this paper relate to differences found between different
files. However, there are a few cases in which naming
inconsistencies can be found within a single file. One
example is an X-ray crystal structure of alcohol dehydroge-
nase [PDB:2OHX] [16]. This structure contains two NAD
molecules (see Figure 2). The prochiral center around
phosphorus atom PN has consistent naming between the
two molecules, however the prochiral center around
phosphorus atom PA does not. In one case the pro-S and
pro-R atoms are named "O1A" and "O2A", respectively,
and in the other case, the names are "O2A" and "O1A",
respectively.
Another example is an NMR structure of bovine acyl-coen-
zyme A binding protein (Figure 3) [PDB:1NVL]. This
structure contained 20 NMR models, in which one phos-
phorus prochiral center was consistently named and the
other was not. For the P1A center, models 1, 2, 5 and 18
have pro-S and pro-R atoms named "O1A" and "O2A",
while the remaining 15 models have them named "O2A"
and "O1A", respectively. Meanwhile, the pro-S and pro-R
atoms at the P2A center are consistently named "O5A"
and "O4A", respectively.
Discussion
The inconsistent naming of atoms discussed in our paper
is due largely to a lack of standardized names, not due to
errors on the part of crystallographers or NMR researchers.
There can be no errors where there are no rules.
A study of NAD(P) molecules by Carugo and Argos
ignored the diastereotopic oxygen atoms for purposes of
superimposing molecules because of naming inconsisten-
cies [17]. Despite their use of atom-specific names for
other atoms in the molecules, they only generally referred
to diastereotopic oxygen atoms as "terminal oxygen
atoms". That was eleven years ago and only involved a
study of 32 protein structures. This was long before the
recent remediation project of the PDB [18]. This project
has done well to bring molecular and atomic naming con-
ventions for PDB files into conformity with standards
established by the International Union of Pure and
Applied Chemistry (IUPAC) and the International Union
of Biochemistry and Molecular Biology (IUBMB). How-
ever, IUPAC and IUBMB do not have standards for most
diastereotopic atoms of small molecules.
There were no obvious overall trends in naming conven-
tions with respect to the pro-R and pro-S atoms. This is
likely due to the lack of naming standardization. How-
ever, trends are commonly seen among specific ligands
(Table 1). One interesting observation is that the P prochi-
ral center of FAD is highly biased in its naming conven-
tion (87% for one convention); however, the second
center, PA has little bias (54% for one convention).
Another observation is that NAD-like ligands tend to have
naming conventions such that similar names (e.g. O1A
and O1N) are seen on the same "side" of the molecule.
We suggest a general rule that names for pro-S atoms come
alphanumerically before names for pro-R atoms. This is
similar to the standard of using "OP1" for pro-S and
"OP2" for pro-R in nucleic acids. The data indicates that
there is no strong bias for this nor for its opposite conven-
tion among diphosphate containing ligands.
Diphosphate of Coenzyme A from NMR structure 1NVL Figure 3
Diphosphate of Coenzyme A from NMR structure 
1NVL. The diphosphate region of coenzyme A of two mod-
els from 1NVL is shown. The diphosphate region of model 4 
(light coloring) is superimposed on the same diphosphate 
region of model 2 (standard coloring). The diastereotopic 
names of prochiral center P2A have consistent names (O4A 
and O5A), but the pro-S and pro-R names for prochiral 
center P1A are not (O1A and O2A, respectively, for model 
2, and O2A and O1A, respectively, for model 4).BMC Bioinformatics 2008, 9(Suppl 9):S16 http://www.biomedcentral.com/1471-2105/9/S9/S16
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Regardless of what rules may become adopted, it is impor-
tant to know to which atom a particular name refers.
Establishing standard names and topologies that take
prochirality into consideration will result in less confu-
sion and more accuracy in studies involving small mole-
cules. Until standards are adopted, individuals mining the
data need to do their own standardization of the names.
This naming can be enforced upfront, prior to the official
release of data, or it can be enforced by individuals mining
the data.
Conclusion
Current naming conventions do not completely map
unique names to unique diastereotopic atoms, resulting
in possible confusion or error, or at least the need for
researchers to impose their own naming standardization.
We herein describe many cases of naming inconsistencies
for small molecules containing diphosphate moieties. A
future study will assess naming conventions of all atoms
in the PDB, addressing more general issues of chirality
and prochirality. The in-house software used in this study
is available upon request.
Methods
Selection of small molecules for analysis
PDB files were selected from the January 7, 2008 "snap-
shot" of the Protein Data Bank. The search feature of the
Protein Data Bank website http://www.pdb.org/pdb/
search/advSearch.do was used to select PDB codes for files
containing ligands that had substructures matching the
SMILES pattern "C~O~P(~O)(~O)~O~P(~O)(~O)~O".
Here, "C" represents a carbon atom, "~" represents any
bond, "O" represents oxygen, "P" represents phosphorus,
and the parentheses indicate that the oxygen atoms inside
them are bonded to the preceding phosphorus atom in
the list, not to subsequent atoms in the list. This matches
any ligand containing a (PO4)2 moiety, such as NAD, ATP,
and Coenzyme A, resulting in a list of 4435 PDB codes.
Since the PDB files corresponding to these codes also
included other ligands not meeting our criteria, we ana-
lyzed each of the small molecules within each PDB file
and selected each one that met the following criteria: (1)
It did not have the same residue name as an amino acid or
nucleic acid, including names mapped to standard residue
names via the "MODRES" record. (2) It had an entry in
the Chemical Component Dictionary http://
deposit.rcsb.org/het_dictionary.txt from the PDB. (3) It
had complete coordinates for the non-hydrogen atoms
specified in the Chemical Component Dictionary. And
(4), it had a diphosphate group attached to carbon, with
the diphosphate group consisting of two phosphorus
atoms, each covalently bonded to four oxygen atoms. We
chose to analyze the prochiral phosphate centers adjacent
to carbon atoms because of their abundance and because
it allowed a simple and direct application of the CIP algo-
rithm.
Atoms were considered to be covalently bonded if the dis-
tance between their centers was less than the sum of their
covalent radii plus a cushion of 0.4 Å, following the cus-
tom of the Cambridge Structural Database (CSD) [19].
Covalent radii were obtained from the CSD website http:/
/www.ccdc.cam.ac.uk/products/csd/radii/.
Also excluded were molecules that had alternate confor-
mations that shared the same residue number. This guar-
anteed that any modeled alternate conformations would
contain complete molecules. Those files containing
diphosphates were further checked for phosphorus atoms
having a prochiral configuration (see Determination of
Prochiral Centers below). For those that did, the names of
all four atoms attached to the prochiral center were
recorded along with their relative stereochemical posi-
tions. Of the 4435 files originally selected, 4184 were
found to have at least one ligand with a prochiral phos-
phate atom.
Determination of prochiral centers
The CIP algorithm [20,21] for assigning priorities to
atoms within a molecule was implemented using in-
house software. CIP priorities were calculated for all four
atoms connected to a phosphorus atom. Following the
CIP-algorithm, the oxygen atom attached to two phos-
phorus atoms always had the highest priority and the oxy-
gen atom attached to carbon always had the second
highest priority. The two remaining oxygen atoms were
not bonded to any other atom besides the phosphorus
atom.
If each atom had a distinct priority, then the phosphorus
is chiral and the determinant algorithm of Cieplak and
Wisniewski[22] could be used to calculate whether the
configuration is R or S as shown in Equation (1):
XN, YN, and ZN are the x, y, and z components of the coor-
dinates for group N. The subscripted letters A, B, C, and D
represent the highest, second highest, third highest, and
lowest priority atoms, respectively (see Figure 1). m is the
result of calculating the determinant. It is negative for the
R configuration and positive for the S configuration. If it
is evaluated to be zero, then the atoms are all in the same
plane [22], which should never be the case for tetrahe-
drally arranged molecules such as phosphates. For under-
XYZ
XYZ
XYZ
XYZ
m
AA A
BB B
CC C
DD D
1
1
1
1
= (1)BMC Bioinformatics 2008, 9(Suppl 9):S16 http://www.biomedcentral.com/1471-2105/9/S9/S16
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standing the mathematics behind this equation and how
it captures the handedness of four three-dimensional
coordinates, we refer the reader to the work of Cieplak and
Wisniewski [22].
If two of the atoms attached to the phosphorus atom have
identical priorities, then they are diastereotopic and the
phosphorus is prochiral. In the case of diphosphate-con-
taining molecules, the diastereotopic atoms are only
bonded to phosphorus and therefore have the lowest pri-
ority (see Figure 2). We will call the atoms attached to the
phosphorus atom A, B, C, and C', where A and B have the
highest and second highest priority, respectively, while C
and C' tie for the lowest priority. In this case, Equation (1)
can be adapted to determine whether C is the pro-S or pro-
R atom and, concomitantly, whether C' is the pro-R or pro-
S atom. By definition, a diastereotopic atom being pro-S
(or pro-R) means that, if it were replaced by a group with
higher priority than any other substituent, then the
prochiral center would become chiral with an S (or R)
configuration. Therefore, we treat C as if it had the highest
priority and then calculate the resulting configuration. If
the calculated configuration is S, then C is pro-S; if it is R,
then C is pro-R. To do this computationally, we artificially
raise the priority of C to be the highest (i.e. higher than A)
changing Equation (1) to the following:
If m is positive, then C is the pro-S atom and, concomi-
tantly, C' is the pro-R atom (Figure 2). If m is negative,
then C is the pro-R atom and C' is the pro-S atom.
Third-party software used
COOT [23] was used for visualizing PDB files, which was
especially useful during the development of our software.
As needed, the SSM [24] module of COOT was also used
for superposition of molecules. Pymol was used for view-
ing NMR models as well as generating depictions of
molecular structures for figures [25].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CAB participated in the design of the study, developed the
in-house software, carried out the atom name analysis,
and drafted the manuscript. DX participated in the design
and coordination of the study, and helped draft the man-
uscript. Both authors read and approved the final manu-
script.
Additional material
Acknowledgements
CAB was supported by NIH Grant Number 2-T15-LM07089-16 from the 
National Library of Medicine. DX was supported by an NIH Grant 
(1R21GM078601-01).
This article has been published as part of BMC Bioinformatics Volume 9 Sup-
plement 9, 2008: Proceedings of the Fifth Annual MCBIOS Conference. Sys-
tems Biology: Bridging the Omics. The full contents of the supplement are 
available online at http://www.biomedcentral.com/1471-2105/9?issue=S9
References
1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H,
Shindyalov IN, Bourne PE: The Protein Data Bank.  Nucleic Acids
Res 2000, 28(1235-242 [http://www.rcsb.org/].
2. Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR,
Ross D, Amzel LM: Structure-based development of anticancer
drugs: complexes of NAD(P)H:quinone oxidoreductase 1
with chemotherapeutic quinones.  Structure 2001, 9(8):659-667.
3. Bressi JC, Verlinde CL, Aronov AM, Shaw ML, Shin SS, Nguyen LN,
Suresh S, Buckner FS, Van Voorhis WC, Kuntz ID, Hol WG, Gelb
MH: Adenosine analogues as selective inhibitors of glyceral-
dehyde-3-phosphate dehydrogenase of Trypanosomatidae
via structure-based drug design.  J Med Chem 2001,
44(13):2080-2093.
4. Newsletter 1984.  European Journal of Biochemistry 1984,
138(1):5-7.
5. Eckstein F: Nucleoside phosphorothioates.  Annu Rev Biochem
1985, 54:367-402.
6. Cech TR, Herschlag D, Piccirilli JA, Pyle AM: RNA catalysis by a
group I ribozyme. Developing a model for transition state
stabilization.  J Biol Chem 1992, 267(25):17479-17482.
7. Padgett RA, Podar M, Boulanger SC, Perlman PS: The stereochem-
i c a l  c o u r s e  o f  g r o u p  I I  intron self-splicing.  Science 1994,
266(5191):1685-1688.
8. Domanico PL, Rahil JF, Benkovic SJ: Unambiguous stereochemi-
cal course of rabbit liver fructose bisphosphatase hydrolysis.
Biochemistry 1985, 24(7):1623-1628.
9. Tsai MD: Use of phosphorus-31 nuclear magnetic resonance
to distinguish bridge and nonbridge oxygens of oxygen-17-
enriched nucleoside triphosphates. Stereochemistry of ace-
XYZ
XYZ
XYZ
XYZ
m
CC C
AA A
BB B
CC C
1
1
1
1 ′′ ′
= (2)
Additional file 1
Supplemental Table 1. Contains Table 1 from this document with about 
four additional pages of examples of naming convention statistics for 
selected ligands.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-9-S9-S16-S1.doc]
Additional file 2
Supplemental Table 2. Contains all of the calculated results, including 
those for prochiral centers that appear only once in the PDB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-9-S9-S16-S2.xls]
Additional file 3
Explanation of Supplemental Table 2. Contains an explanation of the 
columns in Supplemental Table 2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-9-S9-S16-S3.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2008, 9(Suppl 9):S16 http://www.biomedcentral.com/1471-2105/9/S9/S16
Page 7 of 7
(page number not for citation purposes)
tate activation by acetyl coenzyme A synthetase.  Biochemistry
1979, 18(8):1468-1472.
10. Schultze P, Feigon J: Chirality errors in nucleic acid structures.
Nature 1997, 387(6634):668.
11. Waszkowycz B: Towards improving compound selection in
structure-based virtual screening.  Drug Discov Today 2008,
13(5–6):219-226.
12. Good A: Structure-based virtual screening protocols.  Curr
Opin Drug Discov Devel 2001, 4(3):301-307.
13. Berthold CL, Toyota CG, Moussatche P, Wood MD, Leeper F, Rich-
ards NG, Lindqvist Y: Crystallographic snapshots of oxalyl-CoA
decarboxylase give insights into catalysis by nonoxidative
ThDP-dependent decarboxylases.  Structure 2007,
15(7):853-861.
14. Reuter K, Mofid MR, Marahiel MA, Ficner R: Crystal structure of
the surfactin synthetase-activating enzyme sfp: a prototype
of the 4'-phosphopantetheinyl transferase superfamily.  The
EMBO journal 1999, 18(23):6823-6831.
15. Thoden JB, Raushel FM, Wesenberg G, Holden HM: The binding of
inosine monophosphate to Escherichia coli carbamoyl phos-
phate synthetase.  J Biol Chem 1999, 274(32):22502-22507.
16. Al-Karadaghi S, Cedergren-Zeppezauer ES, Hovmoller S: Refined
crystal structure of liver alcohol dehydrogenase-NADH
complex at 1.8 Å resolution.  Acta Crystallogr D Biol Crystallogr
1994, 50:793-807.
17. Carugo O, Argos P: NADP-dependent enzymes. I: Conserved
stereochemistry of cofactor binding.  Proteins 1997,
28(1):10-28.
18. Henrick K, Feng Z, Bluhm WF, Dimitropoulos D, Doreleijers JF,
Dutta S, Flippen-Anderson JL, Ionides J, Kamada C, Krissinel E, Law-
son CL, Markley JL, Nakamura H, Newman R, Shimizu Y, Swami-
nathan J, Velankar S, Ory J, Ulrich EL, Vranken W, Westbrook J,
Yamashita R, Yang H, Young J, Yousufuddin M, Berman HM: Reme-
diation of the protein data bank archive.  Nucleic Acids Res
2008:D426-433.
19. Allen FH: The Cambridge Structural Database: a quarter of a
million crystal structures and rising.  Acta Crystallogr B 2002,
58:380-388.
20. Cahn RS, Ingold C, Prelog V: Specification of molecular chirality.
Angew Chem Int Ed Engl 1966, 5(4):385-415.
21. Prelog V, Helmchen G: Basic principles of the CIP-system and
proposals for a revision.  Angew Chem Int Ed Engl 1982,
21(8):567-583.
22. Cieplak T, Wisniewski J: A new effective algorithm for the
unambiguous identification of the stereochemical character-
istics of compounds during their registration in databases.
Molecules 2001, 6:915-926.
23. Emsley P, Cowtan K: Coot: model-building tools for molecular
graphics.  Acta Crystallogr D Biol Crystallogr 2004, 60(Pt 12 Pt
1):2126-2132.
24. Krissinel E, Henrick K: Secondary-structure matching (SSM), a
new tool for fast protein structure alignment in three dimen-
sions.  Acta Crystallogr D Biol Crystallogr 2004, 60(Pt 12 Pt
1):2256-2268.
25. DeLano WL: The PyMOL molecular graphics system.  2002
[http://pymol.sourceforge.net]. San Carlos, CA, USA: DeLano Scientific